Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 8:2022:1746540.
doi: 10.1155/2022/1746540. eCollection 2022.

Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism

Giorgio Fabiani  1   2   3 , Carlos Henrique Ferreira Camargo  1 , Raul Martins Filho  4 , Gabriel Sampaio Froehner  1 , Hélio Afonso Ghizoni Teive  1   2
Affiliations

Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism

Giorgio Fabiani et al. Parkinsons Dis. .

Abstract

Introduction: Brain SPECT with 99mTc-TRODAT-1 (SPECT-TRODAT) may be a useful tool in the differential diagnosis of Parkinsonism.

Objective: To compare results of SPECT-TRODAT with clinical findings in patients with Parkinsonism.

Methods: We evaluated 153 outpatients. SPECT-TRODAT results were visually analyzed into normal, abnormal, symmetric, and asymmetric, and according to the degree of impairment into mild, moderate, marked, and severe (1-4).

Results: A direct relationship was found between motor scores severity (MDS-UPDRS-III) and SPECT-TRODAT-reduced binding in general, in the group of patients with synucleinopathies (rho = 0.258, p=0.005), especially in patients with Parkinson's disease (rho = 0.204, p=0.049). Changes in SPECT-TRODAT had high correspondence with symmetry in all Parkinsonism. When comparing groups to the correspondence predominantly bilateral or unilateral impairment in SPECT, there was a difference between patients with SNP (p=0.041) and between this group and patients with secondary Parkinsonism (SP) (p < 0.0001). It was handy in differentiating drug-induced Parkinsonism from synucleinopathies. In the group of drug-induced Parkinsonism, younger people were the ones who showed the most significant reductions in radiotracer uptake. In this group, nonmotor signs resulted in examinations with more significant reductions in radiotracer uptake. When the scans without alterations and those that did not correspond to the symmetry were considered negative, SPECT-TRODAT's accuracy and specificity to differentiate PD from other forms of Parkinsonism were low. There was an inverse correlation between the severity of the SPECT-TRODAT result and the absence of nonmotor signs in patients with drug-induced Parkinsonism.

Conclusion: The authors concluded that the SPECT with 99mTc-TRODAT-1 was mainly useful in differentiating between synucleinopathies and secondary Parkinsonism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Degrees of involvement according to radiopharmaceutical uptake in cerebral SPECT with 99mTc-TRODAT-1.
Figure 2
Figure 2
Comparison of SPECT-TRODAT results among patients with Parkinson's disease and other Parkinsonisms∗. ∗Normal results and those that did not correspond to the clinical picture (symmetry) were considered negative. For the calculations, unilateral and bilateral results were considered different. PD = Parkinson's disease, MSA = multisystem atrophy, LBD = Lewy body dementia, DIP = drug-induced Parkinsonism, VP = vascular Parkinsonism.
See this image and copyright information in PMC

References

    1. Poewe W., Seppi K., Tanner C. M., et al. Parkinson disease. Nature Reviews Disease Primers . 2017;3(1) doi: 10.1038/nrdp.2017.13.17013 - DOI - PubMed
    1. Dorsey E. R., Sherer T., Okun M. S., Bloem B. R. The emerging evidence of the Parkinson pandemic. Journal of Parkinson’s Disease . 2018;8(s1):S3–S8. doi: 10.3233/jpd-181474. - DOI - PMC - PubMed
    1. Munhoz R. P., Werneck L. C., Teive H. A. G. The differential diagnoses of Parkinsonism: findings from a cohort of 1528 patients and a 10-years comparison in tertiary movement disorders clinics. Clinical Neurology and Neurosurgery . 2010;112(5):431–435. - PubMed
    1. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry . 1992;55(3):181–184. doi: 10.1136/jnnp.55.3.181. - DOI - PMC - PubMed
    1. Camargo C., Della-Coletta M. V., Da Silva D. J., Teive H. In: Handbook of Research on Critical Examinations of Neurodegenerative Disorders . Sahab Uddin Md., Shah Amran Md., editors. IGI Global, Pennsylvania, PA, USA: 2019. pp. 274–297. - DOI